Communicable diseases news

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.

From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under.

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).

See details on the pre-departure testing requirement for COVID-19 for people travelling to Australia from China, including Hong Kong and Macau.

The Minister for Health has determined the end of the COVIDSafe data period effective from 16 August 2022. All COVIDSafe app data has now been deleted from the National COVIDSafe Data Store. 

The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.

Read the transcript of Chief Medical Officer, Professor Paul Kelly’s interview on ABC News Breakfast on COVID-19.